Investigators searched publication databases for randomized controlled trials of any treatment for anxiety disorders. The primary outcome was the magnitude of symptom improvement compared with controls.
In a recent survey, more than half the college students with ADHD had at least 1 psychiatric disorder. The recent WHO World Mental Health Survey of college students assessed comorbidities in more than 15,000 college freshmen across 9 countries.
Researchers conducted the first randomized clinical trial comparing the effect of selective serotonin reuptake inhibitor treatment vs aerobic exercise on anxiety in patients with coronary heart disease.
Researchers conducted a meta-analysis of 181 publications that contrasted the neural activity of subjects with anxiety with subjects in control groups or healthy subjects in a safe condition with healthy subjects in an unpredictable-threat condition.
Patients with acute respiratory distress syndrome and a preexisting psychiatric illness, particularly generalized anxiety disorder, were more likely to develop intensive care unit delirium.
Women are more likely to experience anxiety and depression, and women and older children are more likely to receive mental health treatment.
Participants in the United States and the Netherlands completed an online survey that evaluated the impact of COVID-19 on situational circumstances, eating disorder symptoms, eating disorder treatment, and general well-being.
For adolescents with generalized anxiety disorder, escitalopram reduces symptoms of anxiety.
The most common subjects of worry were cancer, heart-related diseases, and neurological diseases.
Prevalence of GAD and depressive symptoms was significantly higher in participants younger than 35 years as compared to those aged 35 years or older.
